T

Triomics

HealthOncology AIB2B

Triomics is a company focused on streamlining cancer care through the use of artificial intelligence. Their innovative approach aims to improve patient outcomes and enhance the efficiency of cancer treatment processes. The recent funding will help them further develop their technology and expand their reach in the healthcare market.

Visit website ↗
Total raised
$22M
tracked to date
Latest round
$22M
May 27, 2026
Press coverage
2
outlets tracked

Is this your company?

Claim this profile to get matched with investors who fund Health startups.

Claim this profile →

Funding history

  1. 1
    $22MMay 27, 2026
    Announcement ↗

Triomics in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile